COPD Assessment Test Variability as a Predictor of Exacerbations in Patients with COPD: A Prospective Study Using Virtual Assistant Monitoring
Authors:
- Cristina AljamaCACristina Aljama
- Robson Aparecido PrudenteRPRobson Aparecido Prudente
- Ane Lopez-GonzalezALAne Lopez-Gonzalez
- María SáezMSMaría Sáez
- Suzana E. TanniSTSuzana E. Tanni
- Júlia SampolJSJúlia Sampol
- Núria RodésNRNúria Rodés
- Yesly Esthepannie CarlosYCYesly Esthepannie Carlos
- Mercedes PalleroMPMercedes Pallero
- Sergi MartíSMSergi Martí
- Gerard OrriolsGOGerard Orriols
- Marian RamonMRMarian Ramon
Open Access
- 7 September 2026
- journal article
- research article
- Published by MDPI AG in Advances in Respiratory Medicine
- Vol. 94 (5) , 64
Abstract
Although short-term CAT score variability has been associated with COPD exacerbations, evidence supporting its integration into virtual assistant-based monitoring remains limited. The aim of this study was to assess the short-term variability in CAT scores using a virtual management tool in patients with COPD and to examine its relationship with the prediction of exacerbations. A prospective observational single-center study was conducted in patients aged >35 with COPD and an exacerbator phenotype (≥2 outpatient exacerbations or ≥1 hospitalization in the previous year). Follow-up was performed weekly, including the CAT questionnaire, through calls were conducted by the virtual assistant Tucuvi Health Manager® during a period of one year. A total of 106 patients were included; 64.2% were male, with a mean (SD) age of 66.8 (7.9) years and a median FEV1(%) of 38.8 (30.1–45.0). The mean follow-up was 25 weeks [IQR 20–35], during which 73 (69%) patients experienced ≥1 exacerbation, accounting for 192 episodes (26% of which required hospitalization). A total of 2550 CAT scores were collected. The mean baseline CAT score was 17.9 (7.6), and scores increased significantly during exacerbations compared with non-exacerbation periods and according to exacerbation severity. Each one-point increase in absolute CAT score was associated with an 11.1% increase in the odds of exacerbation (OR: 1.11; 95% CI: 1.08–1.13), while a weekly variation of ≥2 points (MCID) was associated with more than sixfold higher odds (OR: 6.30; 95% CI: 4.28–9.27). The optimal cut-off for CAT change in the prediction of exacerbation risk was 3 points with a ROC curve of 0.773. Weekly deterioration in CAT scores was associated with increased exacerbation risk in patients with COPD. Short-term increases in CAT may serve as clinically useful warning signals for exacerbation.Keywords
Funding Information
- AstraZeneca
This publication has 39 references indexed in Scilit:
- Comparation of predictive value of CAT and change in CAT in the short term for future exacerbation of chronic obstructive pulmonary diseaseAnnals of Medicine, 2022
- Usefulness and acceptance of telephone monitoring by a virtual assistant for patients with COVID-19 following dischargeRevista Clínica Española (English Edition), 2021
- Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD)Cochrane Database of Systematic Reviews, 2021
- Follow-up with Telemedicine in Early Discharge for COPD Exacerbations: Randomized Clinical Trial (TELEMEDCOPD-Trial)COPD: Journal of Chronic Obstructive Pulmonary Disease, 2020
- The variability of respiratory symptoms and associated factors in COPDRespiratory Medicine, 2017
- The CAT (COPD Assessment Test) questionnaire as a predictor of the evolution of severe COPD exacerbationsRespiratory Medicine, 2015
- The COPD assessment test (CAT) assists prediction of COPD exacerbations in high-risk patientsRespiratory Medicine, 2014
- Minimum clinically important difference for the COPD Assessment Test: a prospective analysisThe Lancet Respiratory Medicine, 2014
- Impacto asistencial hospitalario de la EPOC. Peso específico del paciente con EPOC de alto consumo sanitarioArchivos de Bronconeumología, 2001
- Validation of a combined comorbidity indexJournal of Clinical Epidemiology, 1994